Analysis of Differential Expression of microRNAs and Their Target Genes in Prostate Cancer: A Bioinformatics Study on Microarray Gene Expression Data.
- 29 October 2019
- journal article
- Vol. 8 (2), 103-114
- https://doi.org/10.22088/ijmcm.bums.8.2.103
Abstract
Early diagnosis of prostate cancer (PCa) as the second most common cancer in men is not associated with precise and specific results. Thus, alternate methods with high specificity and sensitivity are needed for accurate and timely detection of PCa. MicroRNAs regulate the molecular pathways involved in cancer by targeting multiple genes. The aberrant expression of the microRNAs has been reported in different cancer types including PCa. In this bioinformatics study, we studied differential expression profiles of microRNAs and their target genes in four PCa gene expression omnibus (GEO) databases. PCa diagnostic biomarker candidates were investigated using bioinformatics tools for analysis of gene expression data, microRNA target prediction, pathway and GO annotation, as well as ROC curves. The results of this study revealed significant changes in the expression of 14 microRNAs and 40 relevant target genes, which ultimately composed four combination panels (miR- 375+96+663/ miR- 133b+143- 3p + 205/ C2ORF72 + ENTPD5 + GLYAT11/LAMB3 + NTNG2+TSLP) as candidate biomarkers capable to distinguish between PCa tumor samples and normal prostate tissue samples. These biomarkers may be suggested for a more accurate early diagnosis of PCa patients along with current diagnostic tests.Keywords
This publication has 43 references indexed in Scilit:
- Differential Connectivity in Colorectal Cancer Gene Expression NetworkIranian Biomedical Journal, 2019
- Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysisPeerJ, 2018
- Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysisOncoTargets and Therapy, 2018
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015JAMA Oncology, 2017
- Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approachScientific Reports, 2017
- The Use of Biomarkers in Prostate Cancer Screening and Treatment.Published by IMR Press ,2017
- Integration of tissue metabolomics, transcriptomics and immunohistochemistry revealsERG-and gleason score-specific metabolomic alterations in prostate cancerOncotarget, 2015
- Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomyScientific Reports, 2015
- Molecular pathways and targets in prostate cancerOncotarget, 2014
- Modeling microRNA-mRNA Interactions Using PLS Regression in Human Colon CancerBMC Medical Genomics, 2011